Return to News Categories

ALL NEWS SECTIONS:
MOST POPULAR SECTIONS:
Commentary and Educational Cattle - Hogs / Livestock News Currencies News Energy News Grain News Index News Interest Futures News Metals Futures News Reports: Crops, CFTC, etc Soft Commodities News

Futures and Commodity Market News

Global Pharmaceutical Drugs Market Briefing 2017: Market is Expected to Reach Approx $1100 Billion in 2020 - Research and Markets

DUBLIN, Jan 03, 2018 (BUSINESS WIRE) --

The "Pharmaceutical Drugs Market Global Briefing 2017" report has been added to Research and Markets' offering.

The global pharmaceutical drugs market is expected to reach around $1100 billion in 2020.

The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing.

Pharmaceutical companies produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

Early Rx-To-OTC Switch - Early Rx-to-OTC switch, or switching the product from prescription to non-prescription status, is a key trend in the dermatology drugs market. Traditionally, the Rx-to-OTC status conversion was generally observed at a phase nearing the patent expiry or after. However, forward-thinking companies are now looking at switching from Rx-to-OTC well in advance of the patent expiry of the drug. This helps the manufacturer to capitalize on the market opportunities for the product.

Early Rx-to-OTC switching also provides an additional benefit as a way to recover all the expenses incurred on the product by the company. A key example from the dermatology OTC drugs market for an early switch includes butenafine hydrochloride (Lotrimin Ultra), an anti-fungal drug. The product was reclassified and switched to being an OTC drug in December 2001, long before its patent expiry (April 2017). It is used in the treatment of athlete's foot, jock itch and ringworm infections.

Scope:

Markets Covered: Cardiovascular Drugs, Musculoskeletal Drugs, Oncology Drugs, Anti-infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-urinary Drugs, Gastrointestinal Drugs, Respiratory Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs. Time Series: Five years historic and forecast. Data: Market value in $ billions. Data Segmentations: Regional breakdowns, market share of competitors, key sub segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

Novartis AG Sanofi S.A. F. Hoffmann-La Roche Ltd Pfizer Inc. Gilead Sciences Inc. Johnson & Johnson GlaxosmithKline Plc. Bayer AG Teva Pharmaceuticals Merck & Co.

For more information about this report visit https://www.researchandmarkets.com/research/pvrlzg/global?w=4

http://cts.businesswire.com/ct/CT?id=bwnews&sty=20180103006003r1&sid=cmtx6&distro=nx&lang=en

View source version on businesswire.com: http://www.businesswire.com/news/home/20180103006003/en/

SOURCE: Research and Markets

Research and Markets 
Laura Wood, Senior Manager 
press@researchandmarkets.com 
For E.S.T Office Hours Call 1-917-300-0470 
For U.S./CAN Toll Free Call 1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 
Related Topics: Pharmaceuticals

Copyright Business Wire 2018

Please read the End User Agreement.
By accessing this page, you agree to the terms and conditions of the End User Agreement.

News provided by COMTEX.

Lt Crude 63.44
Nat Gas 3.180
Corn 348 6/8
Cotton #2 81.62
Gold 1335.8
Copper 3.2035
Euro 1.22565
USD Index 90.510
SP500 E-mini 2791.50
DJIA E-mini 25925
close_icon
open_icon